Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05041972
Title ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ambrx, Inc.
Indications

breast cancer

biliary tract cancer

colorectal cancer

ovarian cancer

Advanced Solid Tumor

endometrial cancer

lung non-small cell carcinoma

Therapies

ARX-788

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.